Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 152.49

+1.0%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biotech Jim who wrote (469)	1/22/2000 4:22:00 PM
From: Miljenko Zuanic	Read Replies (1) of 1834

<<In the current tech, biotech and oil drillers rally, I have forced myself to let the profits ride.>> In past five years I tried to get answer on fundamental question: Is it better to stick with appreciated investment or relocate with hope that somewhere else return will be higher? In 95% cases when I did relocate results were negative. If one believe in sector for next 5-10 years and did identify comps which have sound perspective than trying to get near term better results with quick relocation is risky business, imo. In current market it does pay well, but if one compare 5 years period I do doubt anyone results. <<By the way, do you think that the recent action in REGN is simply profit taking? >> I strongly believe that it is short term profit taking. REGN isn't yet discovered, from street and/or professionals. That P&G is very serious with business expansion into Rx-drugs show recent movements. If P&G do merge with AHP/WL REGN will benefit significantly. However, REGN-P&G collaboration can stay as it is (and beyond next three years) for some time. Based on my investment proportion my expectation here are very, very high. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next